HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Research and planning to meet health needs of people living with HIV

As effective treatments for HIV become more widely available in low- and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV.

14 Aug 2014

MRSA and antibiotic resistance is a major health threat

Antibiotic resistance continues at an alarming rate with the indiscriminate overuse of antibiotics given to humans and animals.

13 Aug 2014

Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.

11 Aug 2014

Racial differences in life expectancy vary substantially across U.S. states

Racial differences in life expectancy have declined nationally but still vary substantially across U.S. states, according to a new study by McGill University researchers.

6 Aug 2014

Laboratories at TSRI investigate antibodies to fight Ebola virus

Laboratories at The Scripps Research Institute (TSRI) are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus.

5 Aug 2014

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious Diseases.

5 Aug 2014

Medical education in sub-Saharan Africa is being revitalized through U.S. funded effort

Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.

1 Aug 2014

Johns Hopkins School of Nursing to launch new HIV curriculum for non-physician providers

The 31-year-old Moore Clinic operated by the Johns Hopkins AIDS Service at the School of Medicine is a historic operation — the second-oldest AIDS clinic in the country. But when Jason Farley, PhD, MPH, CRNP, looks nowadays at the makeup of Moore's caregiving staff, he worries that he's seeing too much history.

31 Jul 2014

U.S.-funded effort revitalizes, expands medical education in sub-Saharan Africa

31 Jul 2014

EGPAF and ACS partner to improve access to essential pain medications for HIV people

Today the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer Society (ACS) announced a new partnership to improve access to essential pain medications for people living with HIV in Swaziland.

30 Jul 2014

Tuberculosis in children: an interview with Dr Peter Dodd, University of Sheffield

It was recently announced that new estimates indicated over 650,000 children develop tuberculosis (TB) every year in the 22 countries with a high burden of the disease (HBCs). Which countries are these and why are so many children developing TB in these areas?

29 Jul 2014

EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 (PD-L1).

29 Jul 2014

Non-endoscopic procedure effective in treating severe chronic migraine headaches

A revised version of a surgical procedure to treat severe chronic migraine headaches led to significant symptom relief more than 90 percent of the time in patients treated at Massachusetts General Hospital.

29 Jul 2014

RI Defeats Hepatitis C project aims to eliminate HCV in Rhode Island

Lynn E. Taylor, M.D., director of The Miriam Hospital's HIV/Viral Hepatitis Coinfection program, states in the July, 2014 Rhode Island Medical Journal special edition, "RI Defeats Hep C" that eliminating hepatitis c virus infection (hep c or HCV) is feasible, can provide economic benefits, enhance capacity to address other health challenges, and improve health care disparities.

26 Jul 2014

Immunologic mechanism makes broadly neutralizing antibodies in people infected with HIV

Scientists at Duke Medicine have found an immunologic mechanism that makes broadly neutralizing antibodies in people who are HIV-1 infected.

25 Jul 2014

Clinic-based audio project gives HIV patients a chance to share experiences with diagnosis

The voice on the recording was low and calm as the speaker recounted the telephone call that brought the news he was infected with the human immunodeficiency virus (HIV) that causes AIDS: "My heart just stopped for a little bit and next thing you know I was on the floor flat on my face boohooing, crying like a baby."

24 Jul 2014

EGPAF experts to deliver presentations at AIDS 2014

Experts from the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will give oral presentations, moderate conference events, and exhibit a variety of educational posters and abstracts related to ending AIDS in children.

21 Jul 2014

Drug for reduction of abdominal fat in HIV patients may also reduce fatty liver disease

The only drug to receive FDA approval for reduction of the abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection may also reduce the incidence of fatty liver disease in such patients.

21 Jul 2014

Growth hormone reduces liver fat in HIV-infected patients with excess abdominal fat

In a preliminary study, HIV-infected patients with excess abdominal fat who received the growth hormone-releasing hormone analog tesamorelin for 6 months experienced modest reductions in liver fat, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS.

21 Jul 2014

HIV self-testing increases proportion of adults initiating antiretroviral therapy

Among adults in the African country of Malawi offered HIV self-testing, optional home initiation of care compared with standard HIV care resulted in a significant increase in the proportion of adults initiating antiretroviral therapy, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS.

21 Jul 2014

HIV/AIDS News and Research

Further Reading

Research and planning to meet health needs of people living with HIV

MRSA and antibiotic resistance is a major health threat

Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

Racial differences in life expectancy vary substantially across U.S. states

Laboratories at TSRI investigate antibodies to fight Ebola virus

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

Medical education in sub-Saharan Africa is being revitalized through U.S. funded effort

Johns Hopkins School of Nursing to launch new HIV curriculum for non-physician providers

U.S.-funded effort revitalizes, expands medical education in sub-Saharan Africa

EGPAF and ACS partner to improve access to essential pain medications for HIV people

Tuberculosis in children: an interview with Dr Peter Dodd, University of Sheffield

EMD Serono begins MSB0010718C Phase II study in mMCC patients

Non-endoscopic procedure effective in treating severe chronic migraine headaches

RI Defeats Hepatitis C project aims to eliminate HCV in Rhode Island

Immunologic mechanism makes broadly neutralizing antibodies in people infected with HIV

Clinic-based audio project gives HIV patients a chance to share experiences with diagnosis

EGPAF experts to deliver presentations at AIDS 2014

Drug for reduction of abdominal fat in HIV patients may also reduce fatty liver disease

Growth hormone reduces liver fat in HIV-infected patients with excess abdominal fat

HIV self-testing increases proportion of adults initiating antiretroviral therapy

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News